Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRKS00000780Phase 2Completed
A Phase 2 trial of rivastigmine in cognitive disorder (CD), Mild Cognitive Impairment (MCI), sponsored by University Hospital Cologne. Started Mar 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on DRKS00000780.